Mohammad Ali Kalantar Motamedi1, Alireza Khalaj2, Maryam Mahdavi3, Majid Valizadeh3, Farhad Hosseinpanah3, Maryam Barzin4. 1. Department of Surgery at St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada. 2. Tehran Obesity Treatment Center, Department of Surgery, Faculty of Medicine, Shahed University, Tehran, Iran. 3. Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 4. Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. m.barzin7@gmail.com.
Abstract
BACKGROUND: Patients with morbid obesity commonly have fatty liver disease and elevated liver enzymes. While surgery effectively induces weight loss, bariatric techniques may differ regarding liver function improvement. OBJECTIVES: To evaluate and compare the trends of liver function recovery after gastric bypass surgery (GB) with sleeve gastrectomy (SG). SETTING: University hospitals, Iran. METHODS: Adult bariatric candidates without a history of alcohol consumption or other etiologies of liver disease who underwent SG (n = 682) or GB (n = 355) were included. Trends of weight loss parameters and alanine transaminase (ALT), aspartate transaminase (AST), and alkaline phosphatase (ALP) at 0, 6 (in 90.4%), 12 (in 83.5%), and 24 months (in 67.1%) were compared using generalized estimating equations method. RESULTS: Overall, 1037 patients with mean age of 38.4 ± 11.2 and mean body mass index of 44.9 ± 6.2 kg/m2 were analyzed. Seventy-eight percent of patients had fatty liver by ultrasound. Both GB and SG patients lost significant weight, with GB patients having a higher percentage of excess weight loss at 24 months (80.1% vs. 75.9%, Pbetween-group = .008). SG patients showed more favorable trends in liver chemistries with significantly lower ALT at 12 months and AST and ALP levels at 6 and 12 months. However, the two groups were comparable at 24 months. Significantly more GB patients developed high ALT at 6 and high AST at 6 and 12 months. Undergoing GB was associated with smaller 0-12-month changes in ALT, AST, and ALP. CONCLUSIONS: Bariatric surgery resulted in improvement in liver function parameters, with SG showing advantages over GB in the first postoperative year.
BACKGROUND:Patients with morbid obesity commonly have fatty liver disease and elevated liver enzymes. While surgery effectively induces weight loss, bariatric techniques may differ regarding liver function improvement. OBJECTIVES: To evaluate and compare the trends of liver function recovery after gastric bypass surgery (GB) with sleeve gastrectomy (SG). SETTING: University hospitals, Iran. METHODS: Adult bariatric candidates without a history of alcohol consumption or other etiologies of liver disease who underwent SG (n = 682) or GB (n = 355) were included. Trends of weight loss parameters and alanine transaminase (ALT), aspartate transaminase (AST), and alkaline phosphatase (ALP) at 0, 6 (in 90.4%), 12 (in 83.5%), and 24 months (in 67.1%) were compared using generalized estimating equations method. RESULTS: Overall, 1037 patients with mean age of 38.4 ± 11.2 and mean body mass index of 44.9 ± 6.2 kg/m2 were analyzed. Seventy-eight percent of patients had fatty liver by ultrasound. Both GB and SG patients lost significant weight, with GBpatients having a higher percentage of excess weight loss at 24 months (80.1% vs. 75.9%, Pbetween-group = .008). SG patients showed more favorable trends in liver chemistries with significantly lower ALT at 12 months and AST and ALP levels at 6 and 12 months. However, the two groups were comparable at 24 months. Significantly more GBpatients developed high ALT at 6 and high AST at 6 and 12 months. Undergoing GB was associated with smaller 0-12-month changes in ALT, AST, and ALP. CONCLUSIONS: Bariatric surgery resulted in improvement in liver function parameters, with SG showing advantages over GB in the first postoperative year.
Authors: Roberta Lupoli; Marco Milone; Alessandro Di Minno; Paola Maietta; Pasquale Ambrosino; Mario Musella; Matteo N D Di Minno Journal: Blood Transfus Date: 2014-12-16 Impact factor: 3.443
Authors: Naga Chalasani; Zobair Younossi; Joel E Lavine; Michael Charlton; Kenneth Cusi; Mary Rinella; Stephen A Harrison; Elizabeth M Brunt; Arun J Sanyal Journal: Hepatology Date: 2017-09-29 Impact factor: 17.425
Authors: Jia-Huei Tsai; Linda D Ferrell; Vivian Tan; Matthew M Yeh; Monika Sarkar; Ryan M Gill Journal: Mod Pathol Date: 2017-03-03 Impact factor: 7.842
Authors: Piotr Kalinowski; Rafał Paluszkiewicz; Bogna Ziarkiewicz-Wróblewska; Tadeusz Wróblewski; Piotr Remiszewski; Mariusz Grodzicki; Marek Krawczyk Journal: Ann Surg Date: 2017-11 Impact factor: 12.969
Authors: Tim van Zutphen; Jolita Ciapaite; Vincent W Bloks; Cameron Ackereley; Albert Gerding; Angelika Jurdzinski; Roberta Allgayer de Moraes; Ling Zhang; Justina C Wolters; Rainer Bischoff; Ronald J Wanders; Sander M Houten; Dana Bronte-Tinkew; Tatiana Shatseva; Gary F Lewis; Albert K Groen; Dirk-Jan Reijngoud; Barbara M Bakker; Johan W Jonker; Peter K Kim; Robert H J Bandsma Journal: J Hepatol Date: 2016-06-14 Impact factor: 25.083
Authors: Miller Barreto de Brito E Silva; Francisco Tustumi; Antonio Afonso de Miranda Neto; Anna Carolina Batista Dantas; Marco Aurélio Santo; Ivan Cecconello Journal: Obes Surg Date: 2021-04-13 Impact factor: 4.129